Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.160
+0.630 (17.85%)
Sep 22, 2026, 4:00 PM EDT - Market closed
Cryo-Cell International Ratios and Metrics
Market cap in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| 34 | 35 | 70 | 44 | 37 | 106 | |
Market Cap Growth | -14.22% | -50.45% | 57.66% | 19.09% | -64.74% | 86.59% |
Enterprise Value | 39 | 44 | 80 | 56 | 44 | 101 |
Last Close Price | 4.16 | 4.30 | 8.15 | 4.89 | 3.99 | 9.93 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
PE Ratio | - | - | 173.84 | - | 13.43 | 50.68 |
Forward PE | 37.82 | 56.00 | 78.82 | 252.00 | 48.56 | - |
PS Ratio | 1.08 | 1.10 | 2.19 | 1.41 | 1.23 | 3.66 |
PB Ratio | - | -1.86 | -5.29 | -4.02 | -24.42 | 25.24 |
P/FCF Ratio | 5.49 | 6.60 | 19.38 | 21.31 | - | 17.33 |
P/OCF Ratio | 5.31 | 6.32 | 11.63 | 4.97 | 4.34 | 13.32 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
EV/Sales Ratio | 1.26 | 1.39 | 2.49 | 1.77 | 1.44 | 3.51 |
EV/EBITDA Ratio | 45.16 | 29.99 | 17.74 | 48.19 | 7.34 | 23.74 |
EV/EBIT Ratio | - | 91.24 | 20.99 | - | 9.80 | 31.36 |
EV/FCF Ratio | 6.44 | 8.39 | 22.04 | 26.70 | - | 16.66 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Debt / Equity Ratio | -0.50 | -0.62 | -0.98 | -0.99 | -7.62 | 0.67 |
Debt / EBITDA Ratio | 6.72 | 6.01 | 2.63 | 7.01 | 1.84 | 0.61 |
Debt / FCF Ratio | 1.47 | 2.20 | 3.59 | 5.24 | - | 0.46 |
Net Debt / Equity Ratio | -0.33 | -0.44 | -0.71 | -0.89 | -6.49 | -1.32 |
Net Debt / EBITDA Ratio | 6.66 | 5.63 | 2.11 | 8.50 | 1.66 | -1.29 |
Net Debt / FCF Ratio | 0.95 | 1.57 | 2.62 | 4.71 | -2.75 | -0.91 |
Asset Turnover | 0.50 | 0.50 | 0.51 | 0.50 | 0.48 | 0.54 |
Inventory Turnover | 22.75 | 22.01 | 11.14 | 14.97 | 9.92 | 10.99 |
Quick Ratio | 0.63 | 0.51 | 0.50 | 0.37 | 0.40 | 0.65 |
Current Ratio | 0.71 | 0.59 | 0.58 | 0.45 | 0.49 | 0.75 |
Return on Equity (ROE) | - | - | - | - | 208.38% | 274.30% |
Return on Assets (ROA) | -0.10% | 0.48% | 3.76% | -0.24% | 4.44% | 3.79% |
Return on Invested Capital (ROIC) | -0.24% | 1.14% | 1.30% | -0.58% | 16.90% | 18.15% |
Return on Capital Employed (ROCE) | -0.20% | 1.20% | 8.80% | -0.60% | 9.80% | 8.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Earnings Yield | -7.35% | -7.01% | 0.57% | -21.48% | 7.44% | 1.97% |
FCF Yield | 18.22% | 15.15% | 5.16% | 4.69% | -9.66% | 5.77% |
Dividend Yield | - | 9.30% | 3.07% | - | - | - |
Payout Ratio | - | - | 502.50% | - | - | - |
Buyback Yield / Dilution | 0.21% | 1.75% | 1.54% | 1.69% | -1.46% | -2.72% |
Total Shareholder Return | 0.21% | 11.05% | 4.61% | 1.69% | -1.46% | -2.72% |